|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
12 February 2013 |
|
Main ID: |
ISRCTN28223466 |
|
Date of registration:
|
23/01/2004 |
|
Primary sponsor: |
|
|
Public title:
|
Pilot study of the efficacy of a psychosocial intervention for frequent parasuicide attempters with personality disturbance
N/A |
|
Scientific title:
|
|
|
Date of first enrolment:
|
Jan 1 1996 |
|
Target sample size:
|
34 |
|
Recruitment status: |
Completed/Not recruiting |
|
URL:
|
http://isrctn.org/ISRCTN28223466 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
Peter
Tyrer |
|
Address:
|
St Mary's Hospital Medical School
Patterson Centre
20 South Wharf Road
W2 1PD
London
United Kingdom |
|
Telephone:
|
+44 (0)20 7886 1648 |
|
Email:
|
p.tyrer@ic.ac.uk |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Efficacy of a new brief manualised form of cognitive behaviour therapy in those with personality disturbance within the flamboyant (cluster B) group. Thirty four patients were enrolled and 32 (18 MACT; 14 TAU) were seen at follow-up.
Exclusion criteria: Not provided at time of registration.
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Mental and behavioural disorders: Other mental disorder
|
|
Intervention(s)
|
1. Psychological treatment using a psychoeducational and problem solving approach to suicide behaviour: manual-assisted cognitive-behaviour therapy (MACT)
2. Standard care
|
|
Primary Outcome(s)
|
|
The main outcome measures will be the time of the next parasuicide act (using Linehan's definition of this, which is more minor than an actual suicide attempt). Our expectation is that our experimental treatment will extend this from a mean of three weeks to a mean of three months and this will require a sample size of 30 in each treatment group.
|
|
Secondary Outcome(s)
|
1. Time to first suicidal act
2. Rate of suicidal acts
3. Change in anxiety and depressive symptoms
|
|
Source(s) of Monetary Support
|
|
NHS Executive London (UK)
|
|